ID: ALA4538474

Max Phase: Preclinical

Molecular Formula: C6H10O16P4

Molecular Weight: 462.03

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=P(O)(O)Oc1cc(OP(=O)(O)O)c(OP(=O)(O)O)cc1OP(=O)(O)O

Standard InChI:  InChI=1S/C6H10O16P4/c7-23(8,9)19-3-1-4(20-24(10,11)12)6(22-26(16,17)18)2-5(3)21-25(13,14)15/h1-2H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)

Standard InChI Key:  OFSQKFMVBPORNX-UHFFFAOYSA-N

Associated Targets(Human)

Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 180 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Inositol 1,4,5-trisphosphate 5-phosphatase 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Type I inositol-1,4,5-trisphosphate 5-phosphatase 17 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 21 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 462.03Molecular Weight (Monoisotopic): 461.8919AlogP: -0.43#Rotatable Bonds: 8
Polar Surface Area: 267.04Molecular Species: ACIDHBA: 8HBD: 8
#RO5 Violations: 1HBA (Lipinski): 16HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 1.11CX Basic pKa: CX LogP: -1.86CX LogD: -14.48
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.23Np Likeness Score: 0.49

References

1. White G, Prior C, Mills SJ, Baker K, Whitfield H, Riley AM, Oganesyan VS, Potter BVL, Brearley CA..  (2020)  Regioisomeric Family of Novel Fluorescent Substrates for SHIP2.,  11  (3): [PMID:32184962] [10.1021/acsmedchemlett.9b00368]
2. Whitfield H, Hemmings AM, Mills SJ, Baker K, White G, Rushworth S, Riley AM, Potter BVL, Brearley CA..  (2021)  Allosteric Site on SHIP2 Identified Through Fluorescent Ligand Screening and Crystallography: A Potential New Target for Intervention.,  64  (7.0): [PMID:33724834] [10.1021/acs.jmedchem.0c01944]

Source